Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SI-BONE, Inc.SIBN · Entity 2501 | Director | June 04, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SI-BONE, Inc.
Report date June 04, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 76,679 |
Reported balance
After 2026-06-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 10,957 · Balance 76,679 F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date.
F2: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 8, 2026 21:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 10,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001492082-26-000002 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,679 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 10,957 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 29, 2026 Filed Jun 1, 2026 21:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,500 | $14.14 | $49,487.90 |
DisclosureSEC source: 0001492082-26-000001 · primarydocument.xml · nonDerivative · entry 3 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,722 F2 · price: This transaction was executed in multiple trades at prices ranging from $14.12 USD to $14.15 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 21:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,064 | $0.00 Strike: $4.32 | $0.00 |
DisclosureSEC source: 0001492082-26-000001 · primarydocument.xml · derivative · entry 4 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,064 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 21:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 3,780 | $14.47 | $54,698.87 |
DisclosureSEC source: 0001492082-26-000001 · primarydocument.xml · nonDerivative · entry 2 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,222 F1 · price: This transaction was executed in multiple trades at prices ranging from $14.45 USD to $14.505 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 21:47 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 12,064 | $4.32 | $52,116.48 |
DisclosureSEC source: 0001492082-26-000001 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 23:43 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004607 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,938 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 21:51 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005332 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,263 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 13,657 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 23:08 UTC | SI-BONE, Inc. SIBN · Entity 2501 | SaleCommon Stock | 9,900 | $20.93 | $207,220.86 |
DisclosureSEC source: 0001562180-24-000269 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,361 F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29th, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $20.63 USD to $21.32 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 02, 2024 Filed Jan 9, 2024 23:01 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,111 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001562180-24-000381 · primarydocument.xml · derivative · entry 2 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,111 shares Expires 2024-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| January 02, 2024 Filed Jan 9, 2024 23:01 UTC | SI-BONE, Inc. SIBN · Entity 2501 | Exercise / conversionCommon Stock | 21,111 | $3.24 | $68,399.64 |
DisclosureSEC source: 0001562180-24-000381 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29th, 2023. F2 · balance_after: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:25 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 4,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005108 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,261 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 20:01 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005230 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,395 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,324 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 21:40 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 3,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-004253 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,071 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 3,848 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 22:23 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004583 · primarydocument.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,223 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,797 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:36 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantStock Options (Right to buy) · Derivative | 15,741 | $0.00 Strike: $17.72 | $0.00 |
DisclosureSEC source: 0001562180-19-003566 · primarydocument.xml · derivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,741 Underlying: Common Stock · 15,741 shares Expires 2029-06-12 F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date. Read SEC document |
| October 19, 2018 Filed Oct 19, 2018 20:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | ConversionSeries 6 Preferred Stock · Derivative | 6,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055702 · doc4.xml · derivative · entry 2 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · price: The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 19, 2018 Filed Oct 19, 2018 20:56 UTC | SI-BONE, Inc. SIBN · Entity 2501 | ConversionCommon Stock | 6,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055702 · doc4.xml · nonDerivative · entry 1 Davis Timothy E JR · CIK 0001492082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.